These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7655153)

  • 1. [Initiative of the drug industry].
    el Hajj M
    Bull Cancer; 1995 Mar; 82(3):221-2. PubMed ID: 7655153
    [No Abstract]   [Full Text] [Related]  

  • 2. The future of gene therapy in the UK.
    Seymour LW
    Trends Biotechnol; 2006 Aug; 24(8):347-9. PubMed ID: 16782218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy: cursed or inching towards credibility?
    Branca MA
    Nat Biotechnol; 2005 May; 23(5):519-21. PubMed ID: 15877060
    [No Abstract]   [Full Text] [Related]  

  • 4. The commercial development of gene therapy in Europe and the USA.
    Martin PA; Thomas SM
    Hum Gene Ther; 1998 Jan; 9(1):87-114. PubMed ID: 9458246
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotechnology. French drug industry initiative.
    Anderson C
    Nature; 1991 Oct; 353(6344):487. PubMed ID: 1922346
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotechnology company planned.
    Newmark P
    Nature; 1980 May; 285(5761):124. PubMed ID: 6929407
    [No Abstract]   [Full Text] [Related]  

  • 7. Good science doesn't guarantee good drugs.
    Siegel J
    Biotechnology (N Y); 1995 Jan; 13(1):13. PubMed ID: 9678905
    [No Abstract]   [Full Text] [Related]  

  • 8. It's time for gene therapy to get disruptive!
    Wilson JM
    Hum Gene Ther; 2012 Jan; 23(1):1-3. PubMed ID: 22247960
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy made more accessible?
    Secko D
    CMAJ; 2005 Jul; 173(2):144. PubMed ID: 16027426
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug production with bio- and genetic technological methods].
    Brauer D
    Pharm Unserer Zeit; 1993 Nov; 22(5-6):316-22. PubMed ID: 8121934
    [No Abstract]   [Full Text] [Related]  

  • 11. GeneMedix sets sight on Southeast Asia.
    Fletcher L
    Nat Biotechnol; 2001 Jan; 19(1):12. PubMed ID: 11135537
    [No Abstract]   [Full Text] [Related]  

  • 12. Finding the substance behind the smoke: who is using biotechnology?
    Arunde A; Rose A
    Nat Biotechnol; 1998 Jul; 16(7):596-7. PubMed ID: 9661168
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular display technologies--development and improvement of powerful solutions in medical, pharmaceutical, and sustainable biotechnology.
    Ueda M; Shibasaki S
    Recent Pat Biotechnol; 2010 Nov; 4(3):170. PubMed ID: 21171953
    [No Abstract]   [Full Text] [Related]  

  • 14. How will biotechnology fare in pharma's big plan?
    Nat Biotechnol; 1996 Nov; 14(11):1515. PubMed ID: 9634811
    [No Abstract]   [Full Text] [Related]  

  • 15. Unlocking the money-making potential of RNAi.
    Howard K
    Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
    [No Abstract]   [Full Text] [Related]  

  • 16. Startups on the menu: Circuit Therapeutics.
    Malenka R
    Nat Biotechnol; 2014 Mar; 32(3):216. PubMed ID: 24727768
    [No Abstract]   [Full Text] [Related]  

  • 17. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 18. Rhône-Poulenc to focus biotech work on gene therapy.
    Butler D
    Nature; 1994 May; 369(6476):92. PubMed ID: 8177328
    [No Abstract]   [Full Text] [Related]  

  • 19. Patent office decision puts Genentech out in front.
    Ezzell C
    Nature; 1987 Nov 12-18; 330(6144):97. PubMed ID: 3478596
    [No Abstract]   [Full Text] [Related]  

  • 20. Around the world in a month.
    Nat Biotechnol; 2015 Sep; 33(9):896. PubMed ID: 26348948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.